Vascular development genetic mechanisms and links to vascular disease

Current Topics in Developmental Biology

Volumn 90, Issue C, 2010, Pages 43-72

  Chappell, John C ^a,b   Bautch, Victoria L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; BMP; Endothelial heterogeneity; Genetic disease; Notch; Vasculogenesis; VEGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CALCIUM BINDING PROTEIN; MEMBRANE PROTEIN; NOTCH RECEPTOR; PROTEIN; SERRATE PROTEINS; SIGNAL PEPTIDE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL; BLOOD VESSEL; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

ANIMALS; BLOOD VESSELS; BONE MORPHOGENETIC PROTEINS; CALCIUM-BINDING PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, NOTCH; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955330142     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(10)90002-1     Document Type: Chapter

References (190)

1. Abdalla S.A., Gallione C.J., Barst R.J., Horn E.M., Knowles J.A., Marchuk D.A., Letarte M., Morse J.H. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur. Respir. J. 2004, 23:373-377.
2. Abdalla S.A., Letarte M. Hereditary haemorrhagic telangiectasia: Current views on genetics and mechanisms of disease. J. Med. Genet. 2006, 43:97-110.
3. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
4. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-227.
5. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 2005, 97:512-523.
6. Arthur H.M., Ure J., Smith A.J., Renforth G., Wilson D.I., Torsney E., Charlton R., Parums D.V., Jowett T., Marchuk D.A., Burn J., Diamond A.G. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 2000, 217:42-53.
7. Bautch V.L. Endothelial cells form a phalanx to block tumor metastasis. Cell 2009, 136:810-812.
8. Benedito R., Roca C., Sorensen I., Adams S., Gossler A., Fruttiger M., Adams R.H. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009, 137:1124-1135.
9. Benjamin L.E., Golijanin D., Itin A., Pode D., Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 1999, 103:159-165.
10. Bentley K., Gerhardt H., Bates P.A. Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. J. Theor. Biol. 2008, 250:25-36.
11. Bentley K., Mariggi G., Gerhardt H., Bates P.A. Tipping the balance: Robustness of tip cell selection, migration and fusion in angiogenesis. PLoS Comput. Biol. 2009, 5:e1000549.
12. Beppu H., Ichinose F., Kawai N., Jones R.C., Yu P.B., Zapol W.M., Miyazono K., Li E., Bloch K.D. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 287:L1241-L1247.
13. Blum Y., Belting H.G., Ellertsdottir E., Herwig L., Luders F., Affolter M. Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo. Dev. Biol. 2008, 316:312-322.
14. Boscolo E., Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis 2009, 12:197-207.
15. Braverman I.M., Sibley J. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J. Invest. Dermatol. 1982, 78:12-17.
16. Bray S.J. Notch signalling: A simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 2006, 7:678-689.
17. Bressan M., Davis P., Timmer J., Herzlinger D., Mikawa T. Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation. Dev. Biol. 2009, 326:101-111.
18. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
19. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
20. Chabriat H., Vahedi K., Iba-Zizen M.T., Joutel A., Nibbio A., Nagy T.G., Krebs M.O., Julien J., Dubois B., Ducrocq X., Levasseur M., Mas J.L., Dubois B., Homeyer P., Lyon-Caen O. Clinical spectrum of CADASIL: A study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995, 346:934-939.
21. Chappell J.C., Taylor S.M., Ferrara N., Bautch V.L. Local guidance of emerging vessel sprouts requires soluble flt-1. Dev. Cell. 2009, 17:377-386.
22. Chen T.T., Luque A., Lee S., Anderson S.M., Segura T., Iruela-Arispe M.L. Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells. J. Cell Biol. 2010, 188:595-609.
23. Cleaver O., Tonissen K.F., Saha M.S., Krieg P.A. Neovascularization of the Xenopus embryo. Dev. Dyn. 1997, 210:66-77.
24. Creamer D., Allen M.H., Sousa A., Poston R., Barker J.N. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. Br. J. Dermatol. 1997, 136:859-865.
25. Cueni L.N., Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J. Invest. Dermatol. 2006, 126:2167-2177.
26. Czirok A., Zamir E.A., Szabo A., Little C.D. Multicellular sprouting during vasculogenesis. Curr. Top. Dev. Biol. 2008, 81:269-289.
27. Dahlqvist C., Blokzijl A., Chapman G., Falk A., Dannaeus K., Ibanez C.F., Lendahl U. Functional notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 2003, 130:6089-6099.
28. Damert A., Miquerol L., Gertsenstein M., Risau W., Nagy A. Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development 2002, 129:1881-1892.
29. David L., Feige J.J., Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev. 2009, 20:203-212.
30. de Jesus Perez V.A., Alastalo T.P., Wu J.C., Axelrod J.D., Cooke J.P., Amieva M., Rabinovitch M. Bone morphogenetic protein 2 induces pulmonary angiogenesis via wnt-beta-catenin and wnt-RhoA-rac1 pathways. J. Cell Biol. 2009, 184:83-99.
31. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., Lowik C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002, 143:1545-1553.
32. Deng Z., Morse J.H., Slager S.L., Cuervo N., Moore K.J., Venetos G., Kalachikov S., Cayanis E., Fischer S.G., Barst R.J., Hodge S.E., Knowles J.A. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor II gene. Am. J. Hum. Genet 2000, 67:737-744.
33. Detmar M., Brown L.F., Claffey K.P., Yeo K.T., Kocher O., Jackman R.W., Berse B., Dvorak H.F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 1994, 180:1141-1146.
34. Domenga V., Fardoux P., Lacombe P., Monet M., Maciazek J., Krebs L.T., Klonjkowski B., Berrou E., Mericskay M., Li Z., Tournier-Lasserve E., Gridley T., Joutel A. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004, 18:2730-2735.
35. Duarte A., Hirashima M., Benedito R., Trindade A., Diniz P., Bekman E., Costa L., Henrique D., Rossant J. Dosage-sensitive requirement for mouse dll4 in artery development. Genes Dev. 2004, 18:2474-2478.
36. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., Breitman M., Alitalo K. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998, 282:946-949.
37. Fernandez L.A., Sanz-Rodriguez F., Blanco F.J., Bernabeu C., Botella L.M. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin. Med. Res. 2006, 4:66-78.
38. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 2005, 69(Suppl. 3):11-16.
39. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
40. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
41. Ferrell R.E. Research perspectives in inherited lymphatic disease. Ann. N. Y. Acad. Sci. 2002, 979:39-51.
42. Fischer C., Mazzone M., Jonckx B., Carmeliet P. FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy?. Nat. Rev. Cancer 2008, 8:942-956.
43. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The notch target genes hey1 and hey2 are required for embryonic vascular development. Genes Dev. 2004, 18:901-911.
44. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70.
45. Funahashi Y., Shawber C.J., Vorontchikhina M., Sharma A., Outtz H.H., Kitajewski J. Notch regulates the angiogenic response via induction of VEGFR-1. J. Angiogenes Res. 2010, 2:3.
46. Gaengel K., Genove G., Armulik A., Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:630-638.
47. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., Thurston G., Yancopoulos G.D. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality Due To major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 2004, 101:15949-15954.
48. Gallione C.J., Repetto G.M., Legius E., Rustgi A.K., Schelley S.L., Tejpar S., Mitchell G., Drouin E., Westermann C.J., Marchuk D.A. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004, 363:852-859.
49. Garcia-Cardena G., Comander J., Anderson K.R., Blackman B.R., Gimbrone M.A. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. USA 2001, 98:4478-4485.
50. Gerhardt H., Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003, 314:15-23.
51. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., Jeltsch M., Mitchell C., Alitalo K., Shima D., Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003, 161:1163-1177.
52. Gerhardt H., Ruhrberg C., Abramsson A., Fujisawa H., Shima D., Betsholtz C. Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev. Dyn. 2004, 231:503-509.
53. Ghabrial A.S., Krasnow M.A. Social interactions among epithelial cells during tracheal branching morphogenesis. Nature 2006, 441:746-749.
54. Goldie L.C., Nix M.K., Hirschi K.K. Embryonic vasculogenesis and hematopoietic specification. Organogenesis 2008, 4:257-263.
55. Grego-Bessa J., Luna-Zurita L., del Monte G., Bolos V., Melgar P., Arandilla A., Garratt A.N., Zang H., Mukouyama Y.S., Chen H., Shou W., Ballestar E., Esteller M., Rojas A., Perez-Pomares J.M., de la Pompa J.L. Notch signaling is essential for ventricular chamber development. Dev. Cell. 2007, 12:415-429.
56. Gu C., Rodriguez E.R., Reimert D.V., Shu T., Fritzsch B., Richards L.J., Kolodkin A.L., Ginty D.D. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev. Cell. 2003, 5:45-57.
57. Harrington L.S., Sainson R.C., Williams C.K., Taylor J.M., Shi W., Li J.L., Harris A.L. Regulation of multiple angiogenic pathways by dll4 and notch in human umbilical vein endothelial cells. Microvasc. Res. 2008, 75:144-154.
58. Harrison R.E., Flanagan J.A., Sankelo M., Abdalla S.A., Rowell J., Machado R.D., Elliott C.G., Robbins I.M., Olschewski H., McLaughlin V., Gruenig E., Kermeen F., et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J. Med. Genet. 2003, 40:865-871.
59. Heath V.L., Bicknell R. Anticancer strategies involving the vasculature. Nat. Rev. Clin. Oncol. 2009, 6:395-404.
60. Hellstrom M., Phng L.K., Hofmann J.J., Wallgard E., Coultas L., Lindblom P., Alva J., Nilsson A.K., Karlsson L., Gaiano N., Yoon K., Rossant J., Iruela-Arispe M.L., et al. Dll4 signalling through notch1 regulates formation of tip cells during angiogenesis. Nature 2007, 445:776-780.
61. High F.A., Lu M.M., Pear W.S., Loomes K.M., Kaestner K.H., Epstein J.A. Endothelial expression of the notch ligand jagged1 is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. USA 2008, 105:1955-1959.
62. Hiratsuka S., Minowa O., Kuno J., Noda T., Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 1998, 95:9349-9354.
63. Hirschi K.K., Rohovsky S.A., D'Amore P.A. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 1998, 141:805-814.
64. Hofmann J.J., Iruela-Arispe M.L. Notch signaling in blood vessels: Who is talking to whom about what?. Circ. Res. 2007, 100:1556-1568.
65. Holderfield M.T., Hughes C.C. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ. Res. 2008, 102:637-652.
66. Hong K.H., Lee Y.J., Lee E., Park S.O., Han C., Beppu H., Li E., Raizada M.K., Bloch K.D., Oh S.P. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 2008, 118:722-730.
67. Iruela-Arispe M.L., Davis G.E. Cellular and molecular mechanisms of vascular lumen formation. Dev. Cell. 2009, 16:222-231.
68. Iso T., Maeno T., Oike Y., Yamazaki M., Doi H., Arai M., Kurabayashi M. Dll4-selective notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem. Biophys. Res. Commun. 2006, 341:708-714.
69. Itoh F., Itoh S., Goumans M.J., Valdimarsdottir G., Iso T., Dotto G.P., Hamamori Y., Kedes L., Kato M., ten Dijke P. Synergy and antagonism between notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 2004, 23:541-551.
70. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 2003, 9:685-693.
71. Jain R.K. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
72. Jain R.K., Booth M.F. What brings pericytes to tumor vessels?. J. Clin. Invest. 2003, 112:1134-1136.
73. Jakobsson L., Bentley K., Gerhardt H. VEGFRs and notch: A dynamic collaboration in vascular patterning. Biochem. Soc. Trans. 2009, 37:1233-1236.
74. Jin S.W., Beis D., Mitchell T., Chen J.N., Stainier D.Y. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 2005, 132:5199-5209.
75. Jinnin M., Medici D., Park L., Limaye N., Liu Y., Boscolo E., Bischoff J., Vikkula M., Boye E., Olsen B.R. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat. Med. 2008, 14:1236-1246.
76. Johnson D.W., Berg J.N., Baldwin M.A., Gallione C.J., Marondel I., Yoon S.J., Stenzel T.T., Speer M., Pericak-Vance M.A., Diamond A., Guttmacher A.E., Jackson C.E., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 1996, 13:189-195.
77. Jones E.A., le Noble F., Eichmann A. What determines blood vessel structure? Genetic prespecification vs. hemodynamics. Physiology (Bethesda) 2006, 21:388-395.
78. Jones E.A., Yuan L., Breant C., Watts R.J., Eichmann A. Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. Development 2008, 135:2479-2488.
79. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cecillion M., Marechal E., Maciazek J., Vayssiere C., Cruaud C., et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996, 383:707-710.
80. Joutel A., Tournier-Lasserve E. Notch signalling pathway and human diseases. Semin. Cell. Dev. Biol. 1998, 9:619-625.
81. Kamath B.M., Spinner N.B., Emerick K.M., Chudley A.E., Booth C., Piccoli D.A., Krantz I.D. Vascular anomalies in Alagille syndrome: A significant cause of morbidity and mortality. Circulation 2004, 109:1354-1358.
82. Kamei M., Saunders W.B., Bayless K.J., Dye L., Davis G.E., Weinstein B.M. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 2006, 442:453-456.
83. Kappas N.C., Zeng G., Chappell J.C., Kearney J.B., Hazarika S., Kallianos K.G., Patterson C., Annex B.H., Bautch V.L. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J. Cell Biol. 2008, 181:847-858.
84. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., Betsholtz C., Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 2004, 5:74-80.
85. Karpanen T., Heckman C.A., Keskitalo S., Jeltsch M., Ollila H., Neufeld G., Tamagnone L., Alitalo K. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 2006, 20:1462-1472.
86. Karpanen T., Wirzenius M., Makinen T., Veikkola T., Haisma H.J., Achen M.G., Stacker S.A., Pytowski B., Yla-Herttuala S., Alitalo K. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am. J. Pathol. 2006, 169:708-718.
87. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999, 126:4895-4902.
88. Kearney J.B., Ambler C.A., Monaco K.A., Johnson N., Rapoport R.G., Bautch V.L. Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 2002, 99:2397-2407.
89. Kearney J.B., Bautch V.L. In vitro differentiation of mouse ES cells: Hematopoietic and vascular development. Methods Enzymol. 2003, 365:83-98.
90. Kearney J.B., Kappas N.C., Ellerstrom C., DiPaola F.W., Bautch V.L. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 2004, 103:4527-4535.
91. Keller G. Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev. 2005, 19:1129-1155.
92. Kendall R.L., Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 1993, 90:10705-10709.
93. Kim Y.H., Hu H., Guevara-Gallardo S., Lam M.T., Fong S.Y., Wang R.A. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development 2008, 135:3755-3764.
94. Kluppel M., Wrana J.L. Turning it up a Notch: Cross-talk between TGF beta and Notch signaling. BioEssays 2005, 27:115-118.
95. Kozawa O., Matsuno H., Uematsu T. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: Vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. J. Cell. Biochem. 2001, 81:430-436.
96. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R., Smith G.H., Stark K.L., et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14:1343-1352.
97. Lane K.B., Machado R.D., Pauciulo M.W., Thomson J.R., Phillips J.A., Loyd J.E., Nichols W.C., Trembath R.C. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat. Genet 2000, 26:81-84.
98. Larrivee B., Freitas C., Suchting S., Brunet I., Eichmann A. Guidance of vascular development: Lessons from the nervous system. Circ. Res. 2009, 104:428-441.
99. Lawson N.D., Scheer N., Pham V.N., Kim C.H., Chitnis A.B., Campos-Ortega J.A., Weinstein B.M. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001, 128:3675-3683.
100. Lawson N.D., Vogel A.M., Weinstein B.M. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell. 2002, 3:127-136.
101. le Noble F., Moyon D., Pardanaud L., Yuan L., Djonov V., Matthijsen R., Breant C., Fleury V., Eichmann A. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development 2004, 131:361-375.
102. Lee S., Chen T.T., Barber C.L., Jordan M.C., Murdock J., Desai S., Ferrara N., Nagy A., Roos K.P., Iruela-Arispe M.L. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007, 130:691-703.
103. Lee D., Park C., Lee H., Lugus J.J., Kim S.H., Arentson E., Chung Y.S., Gomez G., Kyba M., Lin S., Janknecht R., Lim D.S., Choi K. ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell 2008, 2:497-507.
104. Lee C.Y., Vogeli K.M., Kim S.H., Chong S.W., Jiang Y.J., Stainier D.Y., Jin S.W. Notch signaling functions as a cell-fate switch between the endothelial and hematopoietic lineages. Curr. Biol. 2009, 19:1616-1622.
105. Leslie J.D., Ariza-McNaughton L., Bermange A.L., McAdow R., Johnson S.L., Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 2007, 134:839-844.
106. Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C., Qi M., Trask B.J., Kuo W.L., Cochran J., Costa T., Pierpont M.E., Rand E.B., Piccoli D.A., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 1997, 16:243-251.
107. Li D.Y., Sorensen L.K., Brooke B.S., Urness L.D., Davis E.C., Taylor D.G., Boak B.B., Wendel D.P. Defective angiogenesis in mice lacking endoglin. Science 1999, 284:1534-1537.
108. Limbourg A., Ploom M., Elligsen D., Sorensen I., Ziegelhoeffer T., Gossler A., Drexler H., Limbourg F.P. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circ. Res. 2007, 100:363-371.
109. Limbourg F.P., Takeshita K., Radtke F., Bronson R.T., Chin M.T., Liao J.K. Essential role of endothelial Notch1 in angiogenesis. Circulation 2005, 111:1826-1832.
110. Lindahl P., Johansson B.R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245.
111. Lindsay E.A. Chromosomal microdeletions: Dissecting del22q11 syndrome. Nat. Rev. Genet. 2001, 2:858-868.
112. Liu D., Wang J., Kinzel B., Mueller M., Mao X., Valdez R., Liu Y., Li E. Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood 2007, 110:1502-1510.
113. Liu Z.J., Xiao M., Balint K., Soma A., Pinnix C.C., Capobianco A.J., Velazquez O.C., Herlyn M. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J. 2006, 20:1009-1011.
114. Lobov I.B., Renard R.A., Papadopoulos N., Gale N.W., Thurston G., Yancopoulos G.D., Wiegand S.J. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl. Acad. Sci. USA 2007, 104:3219-3224.
115. Lucitti J.L., Jones E.A., Huang C., Chen J., Fraser S.E., Dickinson M.E. Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development 2007, 134:3317-3326.
116. Mac Gabhann F., Popel A.S. Systems biology of vascular endothelial growth factors. Microcirculation 2008, 15:715-738.
117. Machado R.D., Aldred M.A., James V., Harrison R.E., Patel B., Schwalbe E.C., Gruenig E., Janssen B., Koehler R., Seeger W., Eickelberg O., Olschewski H., Elliot C.G., Glissmeyer E., Carlquist J., Kim M., Torbicki A., Fijalkowska A., Szewczyk G., Parma J., Abramowicz M.J., Galie N., Morisaki H., Kyotani S., Nakanishi N., Morisaki T., Humbert M., Simonneau G., Sitbon O., Soubrier F., Coulet F., Morrell N.W., Trembath R.C. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum. Mutat 2006, 27:121-132.
118. Mailhos C., Modlich U., Lewis J., Harris A., Bicknell R., Ish-Horowicz D. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 2001, 69:135-144.
119. Makinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., Kauppinen R., Jackson D.G., Kubo H., Nishikawa S., Yla-Herttuala S., Alitalo K. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 2001, 7:199-205.
120. Masumura T., Yamamoto K., Shimizu N., Obi S., Ando J. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2125-2131.
121. Mazzone M., Dettori D., de Oliveira L., Loges R., Schmidt S., Jonckx T., Tian B., Lanahan Y.M., Pollard A.A., Ruiz P., de Almodovar C., De Smet F., et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009, 136:839-851.
122. McAllister K.A., Grogg K.M., Johnson D.W., Gallione C.J., Baldwin M.A., Jackson C.E., Helmbold E.A., Markel D.S., McKinnon W.C., Murrell J., et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 1994, 8:345-351.
123. McCright B., Gao X., Shen L., Lozier J., Lan Y., Maguire M., Herzlinger D., Weinmaster G., Jiang R., Gridley T. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001, 128:491-502.
124. McCright B., Lozier J., Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002, 129:1075-1082.
125. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., Spinner N.B. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 2006, 79:169-173.
126. Moreno-Miralles I., Schisler J.C., Patterson C. New insights into bone morphogenetic protein signaling: Focus on angiogenesis. Curr. Opin. Hematol. 2009, 16:195-201.
127. Morrell N.W. Pulmonary hypertension due to BMPR2 mutation: A new paradigm for tissue remodeling?. Proc. Am. Thorac. Soc. 2006, 3:680-686.
128. Moser M., Binder O., Wu Y., Aitsebaomo J., Ren R., Bode C., Bautch V.L., Conlon F.L., Patterson C. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol. Cell. Biol. 2003, 23:5664-5679.
129. Nimmagadda S., Geetha Loganathan P., Huang R., Scaal M., Schmidt C., Christ B. BMP4 and noggin control embryonic blood vessel formation by antagonistic regulation of VEGFR-2 (Quek1) expression. Dev. Biol. 2005, 280:100-110.
130. Noseda M., Chang L., McLean G., Grim J.E., Clurman B.E., Smith L.L., Karsan A. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: Role of p21Cip1 repression. Mol. Cell. Biol. 2004, 24:8813-8822.
131. Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A., Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S., Chandrasekharappa S.C. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 1997, 16:235-242.
132. Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahoe P.K., Li L., Miyazono K., ten Dijke P., Kim S., Li E. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 2000, 97:2626-2631.
133. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7:359-371.
134. Park C., Lavine K., Mishina Y., Deng C.X., Ornitz D.M., Choi K. Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development 2006, 133:3473-3484.
135. Peirce S.M. Computational and mathematical modeling of angiogenesis. Microcirculation 2008, 15:739-751.
136. Phng L.K., Gerhardt H. Angiogenesis: A team effort coordinated by notch. Dev. Cell. 2009, 16:196-208.
137. Phng L.K., Potente M., Leslie J.D., Babbage J., Nyqvist D., Lobov I., Ondr J.K., Rao S., Lang R.A., Thurston G., Gerhardt H. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev. Cell. 2009, 16:70-82.
138. Pi X., Ren R., Kelley R., Zhang C., Moser M., Bohil A.B., Divito M., Cheney R.E., Patterson C. Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors. J. Cell Biol. 2007, 179:1569-1582.
139. Price R.J., Skalak T.C. Chronic alpha 1-adrenergic blockade stimulates terminal and arcade arteriolar development. Am. J. Physiol. 1996, 271:H752-H759.
140. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J. Clin. Invest. 2008, 118:2372-2379.
141. Reese D.E., Hall C.E., Mikawa T. Negative regulation of midline vascular development by the notochord. Dev. Cell. 2004, 6:699-708.
142. Ren R., Charles P.C., Zhang C., Wu Y., Wang H., Patterson C. Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses. Blood 2007, 109:2847-2853.
143. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
144. Roberts D.M., Kearney J.B., Johnson J.H., Rosenberg M.P., Kumar R., Bautch V.L. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am. J. Pathol. 2004, 164:1531-1535.
145. Roca C., Adams R.H. Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 2007, 21:2511-2524.
146. Roman B.L., Pham V.N., Lawson N.D., Kulik M., Childs S., Lekven A.C., Garrity D.M., Moon R.T., Fishman M.C., Lechleider R.J., Weinstein B.M. Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 2002, 129:3009-3019.
147. Ruchoux M.M., Domenga V., Brulin P., Maciazek J., Limol S., Tournier-Lasserve E., Joutel A. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am. J. Pathol. 2003, 162:329-342.
148. Ruhrberg C., Gerhardt H., Golding M., Watson R., Ioannidou S., Fujisawa H., Betsholtz C., Shima D.T. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 2002, 16:2684-2698.
149. Saharinen P., Tammela T., Karkkainen M.J., Alitalo K. Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 2004, 25:387-395.
150. Sainson R.C., Aoto J., Nakatsu M.N., Holderfield M., Conn E., Koller E., Hughes C.C. Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J. 2005, 19:1027-1029.
151. Sainson R.C., Johnston D.A., Chu H.C., Holderfield M.T., Nakatsu M.N., Crampton S.P., Davis J., Conn E., Hughes C.C. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 2008, 111:4997-5007.
152. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
153. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): A dual regulator for angiogenesis. Angiogenesis 2006, 9:225-230.
154. Shibuya M., Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 2006, 312:549-560.
155. Shutter J.R., Scully S., Fan W., Richards W.G., Kitajewski J., Deblandre G.A., Kintner C.R., Stark K.L. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 2000, 14:1313-1318.
156. Siekmann A.F., Covassin L., Lawson N.D. Modulation of VEGF signalling output by the Notch pathway. BioEssays 2008, 30:303-313.
157. Siekmann A.F., Lawson N.D. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007, 445:781-784.
158. Skalak T.C., Price R.J. The role of mechanical stresses in microvascular remodeling. Microcirculation 1996, 3:143-165.
159. Soker S., Miao H.Q., Nomi M., Takashima S., Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J. Cell. Biochem. 2002, 85:357-368.
160. Sorensen L.K., Brooke B.S., Li D.Y., Urness L.D. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev. Biol. 2003, 261:235-250.
161. Stalmans I., Lambrechts D., De Smet F., Jansen S., Wang J., Maity S., Kneer P., von der Ohe M., Swillen A., Maes C., Gewillig M., Molin D.G., et al. VEGF: A modifier of the del22q11 (DiGeorge) syndrome?. Nat. Med. 2003, 9:173-182.
162. Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 2002, 109:327-336.
163. Stratman A.N., Malotte K.M., Mahan R.D., Davis M.J., Davis G.E. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009, 114:5091-5101.
164. Strilic B., Kucera T., Eglinger J., Hughes M.R., McNagny K.M., Tsukita S., Dejana E., Ferrara N., Lammert E. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev. Cell. 2009, 17:505-515.
165. Suchting S., Freitas C., le Noble F., Benedito R., Breant C., Duarte A., Eichmann A. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl. Acad. Sci. USA 2007, 104:3225-3230.
166. Swift M.R., Weinstein B.M. Arterial-venous specification during development. Circ. Res. 2009, 104:576-588.
167. Takashima S., Kitakaze M., Asakura M., Asanuma H., Sanada S., Tashiro F., Niwa H., Miyazaki Ji J., Hirota S., Kitamura Y., Kitsukawa T., Fujisawa H., et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA 2002, 99:3657-3662.
168. Tammela T., Zarkada G., Wallgard E., Murtomaki A., Suchting S., Wirzenius M., Waltari M., Hellstrom M., Schomber T., Peltonen R., Freitas C., Duarte A., et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008, 454:656-660.
169. Taylor K.L., Henderson A.M., Hughes C.C. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc. Res. 2002, 64:372-383.
170. Teichert-Kuliszewska K., Kutryk M.J., Kuliszewski M.A., Karoubi G., Courtman D.W., Zucco L., Granton J., Stewart D.J. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ. Res. 2006, 98:209-217.
171. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 1991, 266:11947-11954.
172. Trembath R.C., Thomson J.R., Machado R.D., Morgan N.V., Atkinson C., Winship I., Simonneau G., Galie N., Loyd J.E., Humbert M., Nichols W.C., Morrell N.W., et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N. Engl. J. Med. 2001, 345:325-334.
173. Urness L.D., Sorensen L.K., Li D.Y. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat. Genet. 2000, 26:328-331.
174. Valdimarsdottir G., Goumans M.J., Rosendahl A., Brugman M., Itoh S., Lebrin F., Sideras P., ten Dijke P. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 2002, 106:2263-2270.
175. Villa N., Walker L., Lindsell C.E., Gasson J., Iruela-Arispe M.L., Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev. 2001, 108:161-164.
176. Vogeli K.M., Jin S.W., Martin G.R., Stainier D.Y. A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula. Nature 2006, 443:337-339.
177. Vogt R.R., Unda R., Yeh L.C., Vidro E.K., Lee J.C., Tsin A.T. Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells. J. Cell. Biochem. 2006, 98:1196-1202.
178. Whitaker G.B., Limberg B.J., Rosenbaum J.S. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J. Biol. Chem. 2001, 276:25520-25531.
179. Witte M.H., Bernas M.J., Martin C.P., Witte C.L. Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology. Microsc. Res. Tech. 2001, 55:122-145.
180. Xu Y., Yuan L., Mak J., Pardanaud L., Caunt M., Kasman I., Larrivee B., Del Toro R., Suchting S., Medvinsky A., Silva J., Yang J., et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 2010, 188:115-130.
181. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G., Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8:723-730.
182. Yang X., Long L., Southwood M., Rudarakanchana N., Upton P.D., Jeffery T.K., Atkinson C., Chen H., Trembath R.C., Morrell N.W. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ. Res. 2005, 96:1053-1063.
183. Yeh L.C., Lee J.C. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol. Cell. Endocrinol. 1999, 153:113-124.
184. Yoo S.K., Deng Q., Cavnar P.J., Wu Y.I., Hahn K.M., Huttenlocher A. Differential regulation of protrusion and polarity by PI3K during neutrophil motility in live zebrafish. Dev. Cell. 2010, 18:226-236.
185. Yoshimoto M., Yoder M.C. Developmental biology: Birth of the blood cell. Nature 2009, 457:801-803.
186. Young H.S., Summers A.M., Bhushan M., Brenchley P.E., Griffiths C.E. Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J. Invest. Dermatol. 2004, 122:209-215.
187. Yuan L., Moyon D., Pardanaud L., Breant C., Karkkainen M.J., Alitalo K., Eichmann A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002, 129:4797-4806.
188. Zeng G., Taylor S.M., McColm J.R., Kappas N.C., Kearney J.B., Williams L.H., Hartnett M.E., Bautch V.L. Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood 2007, 109:1345-1352.
189. Zhong T.P., Childs S., Leu J.P., Fishman M.C. Gridlock signalling pathway fashions the first embryonic artery. Nature 2001, 414:216-220.
190. Zhong T.P., Rosenberg M., Mohideen M.A., Weinstein B., Fishman M.C. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 2000, 287:1820-1824.